Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 14.80%-7B | ---- | -1,102.12%-8.21B | ---- | -85.71%819.43M | ---- | -12.60%5.74B | ---- | 12.11%6.56B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 69.42%-30M | ---- | 30.91%-98.1M | ---- | 35.85%-141.98M | ---- | 14.62%-221.34M | ---- | 20.29%-259.25M |
| Attributable subsidiary (profit) loss | ---- | -307.45%-346.93M | ---- | -118.74%-85.15M | ---- | 170.91%454.27M | ---- | 0.16%-640.64M | ---- | -315.48%-641.63M |
| Impairment and provisions: | ---- | 31.42%5.04B | ---- | 287.13%3.83B | ---- | 71.34%989.98M | ---- | 154.53%577.79M | ---- | 217.68%227.01M |
| -Impairment of property, plant and equipment (reversal) | ---- | 19.40%3.52B | ---- | 198.17%2.95B | ---- | 71.34%989.98M | ---- | 154.53%577.79M | ---- | 481.55%227.01M |
| -Impairment of trade receivables (reversal) | ---- | 15.36%817.04M | ---- | --708.26M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 303.18%695.04M | ---- | --172.39M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | 31.79%5.09B | ---- | 31,559.68%3.86B | ---- | 106.20%12.2M | ---- | 79.40%-196.86M | ---- | 35.10%-955.8M |
| -Fair value of investment properties (increase) | ---- | 34.57%5.05B | ---- | 14,667.07%3.75B | ---- | 111.40%25.42M | ---- | 62.61%-223.07M | ---- | 57.54%-596.57M |
| -Other fair value changes | ---- | -65.50%36.97M | ---- | 910.00%107.13M | ---- | -150.46%-13.23M | ---- | 107.30%26.21M | ---- | -777.58%-359.24M |
| Asset sale loss (gain): | ---- | -220.05%-46.16M | ---- | 84.91%38.45M | ---- | -78.72%20.79M | ---- | -50.05%97.7M | ---- | 720.72%195.61M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 66.49%-140.71M | ---- | -381.33%-419.88M | ---- | -30.51%149.25M | ---- | 1,347.55%214.79M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 31.48%-1.01M | ---- | -9.53%-1.47M | ---- | 96.31%-1.34M | ---- | -6,037.27%-36.39M | ---- | -136.25%-593K |
| -Loss (gain) from selling other assets | ---- | -125.00%-45.15M | ---- | -59.14%180.63M | ---- | 3,016.28%442.02M | ---- | 18.44%-15.16M | ---- | -32.31%-18.58M |
| Depreciation and amortization: | ---- | -41.22%60.39M | ---- | -20.67%102.74M | ---- | 5.85%129.51M | ---- | 11.89%122.36M | ---- | 13.88%109.35M |
| -Depreciation | ---- | -34.44%52.73M | ---- | 13.44%80.43M | ---- | 28.60%70.9M | ---- | 2.60%55.13M | ---- | 12.04%53.73M |
| -Amortization of intangible assets | ---- | 0.00%167K | ---- | 0.60%167K | ---- | -0.60%166K | ---- | 0.00%167K | ---- | 0.60%167K |
| Financial expense | ---- | 26.89%1.89B | ---- | 62.01%1.49B | ---- | 11.53%921.12M | ---- | 20.97%825.92M | ---- | 29.28%682.78M |
| Special items | ---- | ---- | ---- | -240.86%-131.5M | ---- | ---38.58M | ---- | ---- | ---- | 97.89%-8.65M |
| Operating profit before the change of operating capital | ---- | 481.82%4.66B | ---- | -74.71%800.88M | ---- | -49.74%3.17B | ---- | 6.57%6.3B | ---- | 42.29%5.91B |
| Change of operating capital | ||||||||||
| Developing property (increase)decrease | ---- | -16.25%-8.73B | ---- | 24.21%-7.51B | ---- | 79.33%-9.91B | ---- | -22.85%-47.95B | ---- | -12.41%-39.03B |
| Accounts receivable (increase)decrease | ---- | -147.83%-126.78M | ---- | 305.09%265.07M | ---- | 121.45%65.44M | ---- | -469.11%-305.02M | ---- | 121.73%82.64M |
| Accounts payable increase (decrease) | ---- | 264.19%1.08B | ---- | 88.91%-658.73M | ---- | -899.71%-5.94B | ---- | -168.20%-594.31M | ---- | -88.45%871.4M |
| prepayments (increase)decrease | ---- | 186.73%2.61B | ---- | -83.89%-3.01B | ---- | -144.61%-1.64B | ---- | -22.55%3.67B | ---- | 259.86%4.74B |
| Special items for working capital changes | ---- | -96.92%483.65M | ---- | -50.46%15.72B | ---- | -13.80%31.73B | ---- | 28.39%36.81B | ---- | 24.98%28.67B |
| Cash from business operations | 146.81%312.31M | -100.40%-22.63M | -107.72%-667.14M | -67.95%5.6B | -14.86%8.64B | 947.33%17.47B | 275.25%10.15B | -264.91%-2.06B | -225.81%-5.79B | 136.50%1.25B |
| China income tax paid | 28.10%-255.54M | 16.27%-506.09M | 74.05%-355.42M | 49.01%-604.41M | -42.73%-1.37B | 35.88%-1.19B | 20.94%-959.55M | -12.04%-1.85B | -34.80%-1.21B | -12.44%-1.65B |
| Interest received - operating | -63.82%8.35M | -69.42%30M | -64.06%23.09M | -30.91%98.1M | 30.41%64.24M | -35.85%141.98M | -17.12%49.26M | -14.62%221.34M | -28.71%59.44M | -20.29%259.25M |
| Net cash from operations | 106.52%65.12M | -109.79%-498.71M | -113.62%-999.47M | -68.99%5.09B | -20.60%7.34B | 545.33%16.43B | 233.02%9.24B | -2,531.48%-3.69B | -167.71%-6.95B | 98.02%-140.2M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 673.33%6.96M | -99.25%900K | -95.09%900K | -54.42%119.47M | -76.19%18.33M | -36.25%262.14M | --77.01M | -35.32%411.2M | ---- | 2,003.51%635.77M |
| Restricted cash (increase) decrease | -19.31%164.73M | -80.89%439.92M | 34.48%204.14M | 464.67%2.3B | -77.82%151.8M | 1,186.46%407.62M | 1,254.18%684.48M | 504.40%31.69M | -80.69%50.55M | -106.99%-7.84M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | 888.99%105.03M | 100.18%4.48M | -98.81%10.62M | -290.86%-2.55B | -71.97%890.59M | -209.69%-653.06M | 212.83%3.18B |
| Decrease in deposits (increase) | -53.85%300M | -68.19%649.3M | -68.00%650M | 169.45%2.04B | 231.25%2.03B | -258.97%-2.94B | -189.90%-1.55B | 227.23%1.85B | 226.03%1.72B | -261.14%-1.45B |
| Sale of fixed assets | 4.56%4.45M | -89.89%2.35M | -83.75%4.26M | 110.41%23.28M | 199.94%26.21M | -76.69%11.07M | -62.54%8.74M | 433.55%47.48M | 4,583.94%23.33M | 58.23%8.9M |
| Purchase of fixed assets | 39.91%-11.66M | 41.01%-42.83M | 45.71%-19.41M | 44.91%-72.6M | 48.74%-35.76M | -45.93%-131.8M | -156.59%-69.76M | -21.04%-90.32M | -42.14%-27.19M | 24.51%-74.62M |
| Sale of subsidiaries | 973.93%348.94M | ---- | --32.49M | 10.91%649.7M | ---- | 69.66%585.78M | -102.19%-7.55M | 5.78%345.28M | 1,091.66%345.28M | -38.45%326.42M |
| Acquisition of subsidiaries | ---- | ---- | ---- | -102.65%-13.5M | ---- | 70.90%510.2M | ---- | 378.55%298.54M | ---- | 87.59%-107.18M |
| Recovery of cash from investments | -68.64%37.85M | -49.45%157.8M | -30.72%120.67M | -75.49%312.19M | -9.18%174.18M | 197.67%1.27B | 122.67%191.78M | 245.50%427.97M | 46.51%86.13M | --123.87M |
| Cash on investment | 50.22%-200.96M | 51.74%-778.04M | 58.34%-403.65M | 37.88%-1.61B | 51.38%-968.96M | 30.70%-2.6B | -27.69%-1.99B | 46.08%-3.74B | 15.78%-1.56B | -130.64%-6.94B |
| Other items in the investment business | ---1.78M | ---- | ---- | --190.25M | 147.41%323.73M | ---- | 7,763.28%130.85M | 22,751.46%813.41M | 103.38%1.66M | -105.98%-3.59M |
| Net cash from investment operations | 10.03%648.53M | -89.38%429.41M | -65.83%589.4M | 255.27%4.04B | 133.98%1.73B | -303.54%-2.6B | -39,899.65%-5.08B | 129.63%1.28B | 99.48%-12.69M | 33.07%-4.32B |
| Net cash before financing | 274.03%713.64M | -100.76%-69.3M | -104.53%-410.07M | -33.90%9.14B | 117.67%9.06B | 673.75%13.82B | 159.83%4.16B | 45.97%-2.41B | -38.74%-6.96B | 67.07%-4.46B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 33.23%138.42M | -39.69%863.89M | -90.64%103.9M | -87.14%1.43B | -88.14%1.11B | -57.30%11.14B | -46.28%9.36B | 24.43%26.09B | 66.23%17.43B | 27.69%20.97B |
| Refund | 1.85%-667.7M | 83.17%-1.3B | 88.41%-680.29M | 57.47%-7.73B | 33.52%-5.87B | -3.74%-18.18B | 2.26%-8.83B | -2.39%-17.52B | -45.75%-9.03B | -19.97%-17.11B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -55.90%99.17M |
| Issuance of bonds | ---- | ---- | ---- | 186.37%2.2B | 95.25%1.5B | -81.82%768.25M | -81.75%768.25M | -46.35%4.23B | 292.84%4.21B | -18.23%7.88B |
| Interest paid - financing | 52.71%-305.51M | 62.17%-788.97M | 56.45%-646.11M | 35.69%-2.09B | 11.73%-1.48B | 1.66%-3.24B | -2.96%-1.68B | -1.86%-3.3B | -11.83%-1.63B | ---3.24B |
| Dividends paid - financing | ---- | ---- | ---- | 68.89%-122.43M | ---132M | 65.47%-393.5M | ---- | -24.23%-1.14B | ---- | 17.44%-917.31M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 561.98%805.74M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 99.81%-7.4M | ---- | 29.00%-3.92B | -4.16%-3.27B | -40.95%-5.52B | 19.83%-3.14B | 44.00%-3.92B | -26,753.50%-3.92B | -115.18%-7B |
| Other items of the financing business | ---- | ---- | 153.54%692.42M | 45.28%-3.15B | 60.18%-1.29B | -76.90%-5.75B | -19.76%-3.25B | -274.10%-3.25B | -376.46%-2.71B | -80.39%1.87B |
| Net cash from financing operations | -56.85%-839M | 90.72%-1.24B | 94.34%-534.92M | 37.00%-13.39B | -38.06%-9.44B | -1,985.93%-21.25B | -234.06%-6.84B | -54.81%1.13B | 2.85%5.1B | -85.44%2.49B |
| Effect of rate | 143.50%853K | -109.91%-2.65M | 73.14%-1.96M | 129.07%26.7M | 86.52%-7.3M | 60.22%-91.87M | -90.55%-54.18M | -4,155.19%-230.94M | -183.69%-28.44M | -87.33%5.7M |
| Net Cash | 86.73%-125.36M | 69.14%-1.31B | -147.84%-944.99M | 42.78%-4.25B | 85.76%-381.29M | -479.26%-7.43B | -44.18%-2.68B | 34.75%-1.28B | -3,291.15%-1.86B | -154.74%-1.97B |
| Begining period cash | -33.44%2.62B | -51.79%3.93B | -51.79%3.93B | -47.97%8.16B | -47.97%8.16B | -8.80%15.68B | -8.80%15.68B | -10.23%17.19B | -10.23%17.19B | 23.43%19.15B |
| Cash at the end | -16.49%2.49B | -33.44%2.62B | -61.57%2.99B | -51.79%3.93B | -40.00%7.77B | -47.97%8.16B | -15.42%12.95B | -8.80%15.68B | -19.99%15.31B | -10.23%17.19B |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | --12.95B | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Pak Chun Certified Public Accountants Limited | -- | Shanghui Pak Shing Certified Public Accountants Co., Ltd. | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.